Fluorescence PCR
-
Chlamydia Trachomatis Nucleic Acid
This kit is used for qualitative detection of Chlamydia trachomatis nucleic acid in male urine, male urethral swab, and female cervical swab samples.
-
Enterovirus Universal, EV71 and CoxA16
This kit is used for in vitro qualitative detection of enterovirus, EV71 and CoxA16 nucleic acids in throat swabs and herpes fluid samples of patients with hand-foot-mouth disease, and provides an auxiliary means for the diagnosis of patients with hand-foot-mouth disease.
-
Six kinds of respiratory pathogens
This kit can be used to qualitatively detect the nucleic acid of SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae and respiratory syncytial virus in vitro.
-
Group B Streptococcus Nucleic Acid
This kit is used to qualitatively detect group B streptococcus nucleic acid DNA in vitro rectal swabs, vaginal swabs or rectal/vaginal mixed swabs of pregnant women with high-risk factors around 35 ~37 weeks of pregnancy, and other gestational weeks with clinical symptoms such as premature rupture of membranes, threatened preterm labor, etc.
-
AdV Universal and Type 41 Nucleic Acid
This kit is used for in vitro qualitative detection of adenovirus nucleic acid in nasopharyngeal swabs, throat swabs and stool samples.
-
Mycobacterium Tuberculosis DNA
It is suitable for qualitative detection of Mycobacterium tuberculosis DNA in human clinical sputum samples, and is suitable for auxiliary diagnosis of Mycobacterium tuberculosis infection.
-
14 High-Risk HPV with 16/18 Genotyping
The kit is used for qualitative fluorescence-based PCR detection of nucleic acid fragments specific to 14 human papillomavirus (HPV) types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) in cervical exfoliated cells in women, as well as for HPV 16/18 genotyping to help diagnose and treat HPV infection.
-
SARS-CoV-2 influenza A influenza B Nucleic Acid Combined
This kit is suitable for in vitro qualitative detection of SARS-CoV-2, influenza A and influenza B nucleic acid of the nasopharyngeal swab and oropharyngeal swab samples which of the people who were suspected infection of SARS-CoV-2, influenza A and influenza B.
-
Real-time fluorescent RT-PCR kit for detecting SARS-CoV-2
This kit is intended to in vitro qualitatively detect the ORF1ab and N genes of novel coronavirus (SARS-CoV-2) in the nasopharyngeal swab and oropharyngeal swab collected from cases and clustered cases suspected with novel coronavirus-infected pneumonia and others required for the diagnosis or differential diagnosis of novel coronavirus infection.
